The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Respiratory Disease Testing & Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The global Respiratory Disease Testing & Diagnostics market size is expected to reach US$ 5165.8 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Disease Testing & Diagnostics in various end use industries. The expanding demands from the Hospitals, Physician Clinics, Clinical Laboratories and Other, are propelling Respiratory Disease Testing & Diagnostics market. Imaging Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Respiratory Measurement segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Disease Testing & Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Disease Testing & Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Disease Testing & Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Disease Testing & Diagnostics covered in this report include Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories and Medtronic, etc.
The global Respiratory Disease Testing & Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Global Respiratory Disease Testing & Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Disease Testing & Diagnostics market, Segment by Type:
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Global Respiratory Disease Testing & Diagnostics market, by Application
Hospitals
Physician Clinics
Clinical Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Disease Testing & Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The global Respiratory Disease Testing & Diagnostics market size is expected to reach US$ 5165.8 million by 2029, growing at a CAGR of 1.9% from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Disease Testing & Diagnostics in various end use industries. The expanding demands from the Hospitals, Physician Clinics, Clinical Laboratories and Other, are propelling Respiratory Disease Testing & Diagnostics market. Imaging Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Respiratory Measurement segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Respiratory Disease Testing & Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Disease Testing & Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Disease Testing & Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Disease Testing & Diagnostics covered in this report include Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories and Medtronic, etc.
The global Respiratory Disease Testing & Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Global Respiratory Disease Testing & Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Disease Testing & Diagnostics market, Segment by Type:
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Global Respiratory Disease Testing & Diagnostics market, by Application
Hospitals
Physician Clinics
Clinical Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Respiratory Disease Testing & Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Respiratory Disease Testing & Diagnostics
1.1 Respiratory Disease Testing & Diagnostics Market Overview
1.1.1 Respiratory Disease Testing & Diagnostics Product Scope
1.1.2 Respiratory Disease Testing & Diagnostics Market Status and Outlook
1.2 Global Respiratory Disease Testing & Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Respiratory Disease Testing & Diagnostics Market Size by Region (2018-2029)
1.4 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Respiratory Disease Testing & Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
1.6.1 North America Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
1.6.2 Europe Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
1.6.4 Latin America Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
2 Respiratory Disease Testing & Diagnostics Market by Type
2.1 Introduction
2.1.1 Imaging Test
2.1.2 Respiratory Measurement
2.1.3 Blood Gas Test
2.1.4 Other
2.2 Global Respiratory Disease Testing & Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Respiratory Disease Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Respiratory Disease Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Respiratory Disease Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Respiratory Disease Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Respiratory Disease Testing & Diagnostics Revenue Breakdown by Type (2018-2029)
3 Respiratory Disease Testing & Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Physician Clinics
3.1.3 Clinical Laboratories
3.1.4 Other
3.2 Global Respiratory Disease Testing & Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Respiratory Disease Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Respiratory Disease Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Respiratory Disease Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Respiratory Disease Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Respiratory Disease Testing & Diagnostics Revenue Breakdown by Application (2018-2029)
4 Respiratory Disease Testing & Diagnostics Competition Analysis by Players
4.1 Global Respiratory Disease Testing & Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Disease Testing & Diagnostics as of 2022)
4.3 Date of Key Players Enter into Respiratory Disease Testing & Diagnostics Market
4.4 Global Top Players Respiratory Disease Testing & Diagnostics Headquarters and Area Served
4.5 Key Players Respiratory Disease Testing & Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Respiratory Disease Testing & Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton Dickinson
5.1.1 Becton Dickinson Profile
5.1.2 Becton Dickinson Main Business
5.1.3 Becton Dickinson Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.1.4 Becton Dickinson Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Becton Dickinson Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.2.4 Abbott Laboratories Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.3.4 Abbott Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Cepheid Recent Developments
5.4 Cepheid
5.4.1 Cepheid Profile
5.4.2 Cepheid Main Business
5.4.3 Cepheid Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.4.4 Cepheid Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Cepheid Recent Developments
5.5 Fischer and Paykel
5.5.1 Fischer and Paykel Profile
5.5.2 Fischer and Paykel Main Business
5.5.3 Fischer and Paykel Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.5.4 Fischer and Paykel Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Fischer and Paykel Recent Developments
5.6 Futuremed
5.6.1 Futuremed Profile
5.6.2 Futuremed Main Business
5.6.3 Futuremed Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.6.4 Futuremed Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Futuremed Recent Developments
5.7 Hoffmann-La Roche
5.7.1 Hoffmann-La Roche Profile
5.7.2 Hoffmann-La Roche Main Business
5.7.3 Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.7.4 Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Hoffmann-La Roche Recent Developments
5.8 Instrumentation Laboratories
5.8.1 Instrumentation Laboratories Profile
5.8.2 Instrumentation Laboratories Main Business
5.8.3 Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.8.4 Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Instrumentation Laboratories Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.9.4 Medtronic Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 NDD Medical Technologies
5.10.1 NDD Medical Technologies Profile
5.10.2 NDD Medical Technologies Main Business
5.10.3 NDD Medical Technologies Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.10.4 NDD Medical Technologies Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 NDD Medical Technologies Recent Developments
5.11 Nihon Kohden
5.11.1 Nihon Kohden Profile
5.11.2 Nihon Kohden Main Business
5.11.3 Nihon Kohden Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.11.4 Nihon Kohden Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Nihon Kohden Recent Developments
5.12 Philips Medical Systems
5.12.1 Philips Medical Systems Profile
5.12.2 Philips Medical Systems Main Business
5.12.3 Philips Medical Systems Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.12.4 Philips Medical Systems Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Philips Medical Systems Recent Developments
5.13 SDI Diagnostics
5.13.1 SDI Diagnostics Profile
5.13.2 SDI Diagnostics Main Business
5.13.3 SDI Diagnostics Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.13.4 SDI Diagnostics Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 SDI Diagnostics Recent Developments
5.14 Seegene
5.14.1 Seegene Profile
5.14.2 Seegene Main Business
5.14.3 Seegene Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.14.4 Seegene Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Seegene Recent Developments
5.15 Smiths Medical
5.15.1 Smiths Medical Profile
5.15.2 Smiths Medical Main Business
5.15.3 Smiths Medical Respiratory Disease Testing & Diagnostics Products, Services and Solutions
5.15.4 Smiths Medical Respiratory Disease Testing & Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Smiths Medical Recent Developments
6 North America
6.1 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Respiratory Disease Testing & Diagnostics Market Dynamics
11.1 Respiratory Disease Testing & Diagnostics Industry Trends
11.2 Respiratory Disease Testing & Diagnostics Market Drivers
11.3 Respiratory Disease Testing & Diagnostics Market Challenges
11.4 Respiratory Disease Testing & Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
